Form EFFECT Evogene Ltd.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 3, 2026 |
| Accession Number: | 0001178913-26-001777 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evogene to Present Its Pharma Division Achievements at the BIO International Convention
- Stuart Piltch Scholarship for Entrepreneurs Opens 2026 Application Cycle for Undergraduate Innovators
- BTU Additional Details Regarding Recent Acquisition
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
